{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:03:57Z","timestamp":1790503437508,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013905","name":"Swiss Vaccine Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030-149746"],"award-info":[{"award-number":["310030-149746"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_170108"],"award-info":[{"award-number":["310030_170108"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CR2312-143754"],"award-info":[{"award-number":["CR2312-143754"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006390","name":"Universit\u00e9 de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.virol.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T19:01:17Z","timestamp":1506625277000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein"],"prefix":"10.1016","volume":"512","author":[{"given":"Clara","family":"Galan-Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Rincon-Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Hubbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Hirosue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody A.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2017.09.013_bib1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","article-title":"Clinical sequencing uncovers origins and evolution of lassa virus","volume":"162","author":"Andersen","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.virol.2017.09.013_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-2498-1_3","article-title":"Tracking early T follicular helper cell differentiation in vivo","volume":"1291","author":"Baumjohann","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2017.09.013_bib3","doi-asserted-by":"crossref","first-page":"e25858","DOI":"10.1371\/journal.pone.0025858","article-title":"A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon","volume":"6","author":"Berger Rentsch","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.virol.2017.09.013_bib4","doi-asserted-by":"crossref","first-page":"e1000080","DOI":"10.1371\/journal.pbio.1000080","article-title":"Impaired antibody response causes persistence of prototypic T cell-contained virus","volume":"7","author":"Bergthaler","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.virol.2017.09.013_bib5","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.virol.2017.09.013_bib6","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1128\/jvi.66.12.7270-7281.1992","article-title":"Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus","volume":"66","author":"Borrow","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib7","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1128\/JVI.00761-09","article-title":"Unusual molecular architecture of the machupo virus attachment glycoprotein","volume":"83","author":"Bowden","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"Branco","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2017.09.013_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ni.3158","article-title":"Antibody responses to envelope glycoproteins in HIV-1 infection","volume":"16","author":"Burton","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2017.09.013_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.1225416","article-title":"Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses","volume":"337","author":"Burton","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.virol.2017.09.013_bib11","first-page":"109","article-title":"A model for neutralization of viruses based on antibody coating of the virion surface","volume":"260","author":"Burton","year":"2001","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"10.1016\/j.virol.2017.09.013_bib12","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.virol.2017.09.013_bib13","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1128\/JVI.00651-15","article-title":"Molecular Mechanism for LAMP1 Recognition by Lassa Virus","volume":"89","author":"Cohen-Dvashi","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2016.08.012","article-title":"Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies","volume":"133","author":"Cross","year":"2016","journal-title":"Antivir. Res"},{"key":"10.1016\/j.virol.2017.09.013_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5501\/wjv.v4.i3.265","article-title":"Next-generation sequencing in clinical virology: discovery of new viruses","volume":"4","author":"Datta","year":"2015","journal-title":"World J. Virol."},{"issue":"Pt 8","key":"10.1016\/j.virol.2017.09.013_bib16","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1099\/0022-1317-64-8-1689","article-title":"Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains","volume":"64","author":"Dutko","year":"1983","journal-title":"J. General. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.0818-9641.2004.01243.x","article-title":"T cell activation: in vivo veritas","volume":"82","author":"Fazekas de St Groth","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virol.2017.09.013_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","article-title":"Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice","volume":"311","author":"Fisher-Hoch","year":"1995","journal-title":"Bmj"},{"key":"10.1016\/j.virol.2017.09.013_bib19","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2017.09.013_bib20","doi-asserted-by":"crossref","first-page":"11504","DOI":"10.1128\/JVI.01893-13","article-title":"Role of DC-SIGN in Lassa Virus Entry into Human Dendritic Cells","volume":"87","author":"Goncalves","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nsmb.3210","article-title":"Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV","volume":"23","author":"Hastie","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2017.09.013_bib22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1126\/science.aam7260","article-title":"Structural basis for antibody-mediated neutralization of Lassa virus","volume":"356","author":"Hastie","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.virol.2017.09.013_bib23","doi-asserted-by":"crossref","first-page":"19967","DOI":"10.1073\/pnas.1108910108","article-title":"X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation","volume":"108","author":"Igonet","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2017.09.013_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1743-422X-5-161","article-title":"Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding","volume":"5","author":"Illick","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2017.09.013_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","article-title":"Clinical virology of Lassa fever in hospitalized patients","volume":"155","author":"Johnson","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.09.013_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro1819","article-title":"The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus","volume":"6","author":"Karlsson Hedestam","year":"2008","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.virol.2017.09.013_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0042-6822(03)00421-5","article-title":"Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions","volume":"314","author":"Kunz","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.013_bib28","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/JVI.79.10.5979-5987.2005","article-title":"Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan","volume":"79","author":"Kunz","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.200104103","article-title":"Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan","volume":"155","author":"Kunz","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.virol.2017.09.013_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.virol.2004.05.009","article-title":"Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus","volume":"325","author":"Kunz","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.013_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2013.04.010","article-title":"Pathogenesis of Lassa fever virus infection: i. Susceptibility of mice to recombinant Lassa Gp\/LCMV chimeric virus","author":"Lee","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.013_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jmoldx.2015.07.004","article-title":"Next-generation sequencing for infectious disease diagnosis and management: a report of the association for molecular pathology","volume":"17","author":"Lefterova","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.virol.2017.09.013_bib33","doi-asserted-by":"crossref","first-page":"e1005418","DOI":"10.1371\/journal.ppat.1005418","article-title":"Acidic pH-Induced conformations and LAMP1 binding of the lassa virus glycoprotein spike","volume":"12","author":"Li","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2017.09.013_bib34","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"10.1016\/j.virol.2017.09.013_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.09.013_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2017.09.013_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"37","author":"McCormick","year":"1992","journal-title":"J. Med Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/v8090254","article-title":"Quantification of Lyssavirus-neutralizing antibodies using vesicular stomatitis virus pseudotype particles","volume":"8","author":"Moeschler","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2017.09.013_bib39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/cmi.12078","article-title":"Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan","volume":"15","author":"Moraz","year":"2013","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.virol.2017.09.013_bib40","doi-asserted-by":"crossref","first-page":"e1003212","DOI":"10.1371\/journal.ppat.1003212","article-title":"Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials","volume":"9","author":"Olschlager","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2017.09.013_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00257-16","article-title":"Lassa virus cell entry via dystroglycan involves an unusual pathway of macropinocytosis","author":"Oppliger","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-2776(01)77018-6","article-title":"The antiviral activity of antibodies in vitro and in vivo","volume":"77","author":"Parren","year":"2001","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.virol.2017.09.013_bib43","doi-asserted-by":"crossref","first-page":"e1002232","DOI":"10.1371\/journal.ppat.1002232","article-title":"Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport","volume":"7","author":"Pasqual","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2017.09.013_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/nri.2016.138","article-title":"Immunobiology of Ebola and Lassa virus infections","author":"Prescott","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2017.09.013_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature05539","article-title":"Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses","volume":"446","author":"Radoshitzky","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.virol.2017.09.013_bib46","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2017.09.013_bib47","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1462-5822.2012.01784.x","article-title":"Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan","volume":"14","author":"Rojek","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.virol.2017.09.013_bib48","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1128\/JVI.00560-08","article-title":"Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses","volume":"82","author":"Rojek","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib49","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1099\/0022-1317-70-5-1125","article-title":"Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses","volume":"70","author":"Sanchez","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib50","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1016\/j.biomaterials.2012.04.060","article-title":"Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes","volume":"33","author":"Scott","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.virol.2017.09.013_bib51","doi-asserted-by":"crossref","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","article-title":"Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2017.09.013_bib52","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1128\/JVI.00236-14","article-title":"Evolution of recombinant lymphocytic choriomeningitis virus\/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness","volume":"88","author":"Sommerstein","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib53","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.biomaterials.2013.02.024","article-title":"Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles","volume":"34","author":"Stano","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.virol.2017.09.013_bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jmv.1890140402","article-title":"Effect of environmental factors on aerosol-induced Lassa virus infection","volume":"14","author":"Stephenson","year":"1984","journal-title":"J. Med Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12992-017-0233-9","article-title":"Global research trends of World Health Organization's top eight emerging pathogens","volume":"13","author":"Sweileh","year":"2017","journal-title":"Glob. Health"},{"key":"10.1016\/j.virol.2017.09.013_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jim.2009.08.009","article-title":"Cloning and expression of murine Ig genes from single B cells","volume":"350","author":"Tiller","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2017.09.013_bib57","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1128\/JVI.02251-14","article-title":"Probing the sites of interactions of rotaviral proteins involved in replication","volume":"88","author":"Viskovska","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.013_bib58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.coi.2010.02.012","article-title":"Rational antibody-based HIV-1 vaccine design: current approaches and future directions","volume":"22","author":"Walker","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virol.2017.09.013_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2012.12.009","article-title":"Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics","volume":"84","author":"Webster","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.virol.2017.09.013_bib60","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/v4102031","article-title":"Pathogenesis of Lassa fever","volume":"4","author":"Yun","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2017.09.013_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coviro.2016.01.006","article-title":"Antibody therapeutics for Ebola virus disease","volume":"17","author":"Zeitlin","year":"2016","journal-title":"Curr. Opin. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217303227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217303227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:49Z","timestamp":1758588169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682217303227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":61,"alternative-id":["S0042682217303227"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2017.09.013","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}